There are 2789 resources available
1291P - A phase II study of nivolumab rechallenge therapy in advanced NSCLC patients who responded to prior anti-PD-1/L1 inhibitors: West Japan Oncology Group 9616L
Presenter: Shunsuke Teraoka
Session: ePoster Display
1332P - A randomized phase II trial of standard versus low-dose nab-paclitaxel for previously treated advanced non-small cell lung cancer (JMTO LC14-01)
Presenter: Susumu Takeuchi
Session: ePoster Display
1333P - Dose and schedule modifications of carboplatin plus nab-paclitaxel for elderly patients with squamous non-small cell lung cancer from the CAPITAL study
Presenter: Go Saito
Session: ePoster Display
1335P - Updated results from a phase I/II study of anlotinib plus docetaxel vs docetaxel as second-line treatment of advanced non-small cell lung cancer (NSCLC)
Presenter: Yong Fang
Session: ePoster Display
1337P - Clinical study of apatinib combined with radiation therapy in advanced non-small cell lung cancer patients with brain metastasis
Presenter: Xiaqin Zhang
Session: ePoster Display
1338P - A phase III study comparing BCD-021, a bevacizumab biosimilar, and reference bevacizumab in patients with stage IIIB or IV non-squamous NSCLC
Presenter: Natalia Fadeeva
Session: ePoster Display